Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03738774 · ClinicalTrials.gov registry record

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

A clinical trial of Post-Intensive Care Syndrome, sponsored by Vanderbilt University Medical Center.

Active
Registry status
200
Enrollment target
5
Study locations

NCT03738774 is a study of Post-Intensive Care Syndrome that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 200 participants, above the 155-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (29% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03738774, a study of Post-Intensive Care Syndrome, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
5
Study locations

Study Summary

This study will assess the relationship between early unmet needs after hospital discharge and subsequent clinical outcomes among survivors of acute respiratory failure. The investigators hypothesize that early unmet needs are associated with poor outcomes at three months.

Study Locations (5)

Utah

  • Intermountain Medical Center - Murray
  • George Wahlen Salt Lake City Veterans Administration Hospital - Salt Lake City

Maryland

  • Johns Hopkins Hospital - Baltimore

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-01-02
Est. Completion 2026-07

What the Registry Record Tells You About NCT03738774

The ClinicalTrials.gov registry entry for NCT03738774 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 155-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (29% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Intensive Care Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT03738774 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Utah, Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03738774 about?

NCT03738774 is a clinical study titled "Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)". This study will assess the relationship between early unmet needs after hospital discharge and subsequent clinical outcomes among survivors of acute respiratory failure. The investigators hypothesize that early unmet needs are associated with poor outcomes at three months.

What is the current status of trial NCT03738774?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2019-01-02. Estimated completion is 2026-07.

What conditions does trial NCT03738774 study?

This clinical trial studies the following conditions: Post-Intensive Care Syndrome.

Who is sponsoring clinical trial NCT03738774?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03738774 being conducted?

This trial has 5 study locations across Maryland, Massachusetts, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Intensive Care Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.